Clinical Trial Update: Efficacy & Safety of TD-1473 in Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial of TD-1473 for ulcerative colitis was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• TD-1473

Snippet

Sponsor: Theravance Biopharma | Conditions: Ulcerative Colitis (UC) | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2022-11-15